logo

Acrivon Therapeutics Inc (ACRV) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Acrivon Therapeutics Inc’s current trading price is -35.03% away from its 52-week high, while its distance from the 52-week low is 191.22%. The stock’s price range over this period has fluctuated between $3.19 and $14.30. The company, operating within the financial sector, had a trading volume of approximately 17.84 million for the day, which was noticeably higher than the average daily share volume of 73590.0 over the last 3 months.

Acrivon Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $14.30 on 05/16/23 and a low of $3.19 for the same time frame on 02/13/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Acrivon Therapeutics Inc (ACRV) has experienced a quarterly rise of 121.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 206.15M and boasts a workforce of 58 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.81, with a change in price of +5.15. Similarly, Acrivon Therapeutics Inc recorded 219,177 in trading volume during the last 100 days, posting a change of +112.94%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ACRV stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.

ACRV Stock Stochastic Average

Today, Acrivon Therapeutics Inc’s raw stochastic average for the past 50 days stands at 94.49%, indicating a rise from the raw stochastic average of the last 20 days, which was 92.71%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 66.36% and 63.59% respectively.

ACRV Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 88.82%.However, over the last six months, we can see a weaker performance of 28.14%. Over the last 30 days, the price of ACRV has fallen by 87.68%. And in the last five days, it has surged by 38.86%.